Infusion Therapy Market

Infusion Therapy Market (Product: Infusion Pumps, Infusion Set, and Accessories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Infusion Therapy Market Outlook 2031

  • The industry was valued at US$ 41.7 Bn in 2021
  • It is projected to grow at a CAGR of 6.7% from 2022 to 2031 and reach more than US$ 78.9 Mn by the end of 2031

Analysts’ Viewpoint

Infusion therapy involves usage of sterilized needles and catheters to administer a drug via non-oral routes such as intramuscular injections and epidural routes. Rise in prevalence of chronic diseases, such as cancer, neurological diseases, and gastrointestinal diseases, is expected to drive the global market from 2021 to 2031. Increase in elderly population, changing infusion therapy demand environment, and severe orthopedic diseases are boosting the global infusion therapy market share.

Development of advanced, cost-effective, and user-friendly home infusion kits presents significant opportunities for manufacturers in the business in the next few years. Key players are focusing on strategies such as merger & acquisition, new product launches, and technological innovations to increase their market footprint.

Infusion Therapy Market

Global Infusion Therapy Market Overview

Infusion therapy is used to treat medical conditions, such as infections and diseases, that do not respond to oral antibiotics. An infusion therapy provider is someone who specializes in administering infusion therapies to patients in their homes or other alternative settings. This is referred to as a home infusion therapy pharmacy. Comprehensive service, prescription drugs, and biologics can be safely and effectively administered in patients' homes or other locations.

Rise in hospital-acquired infections (HAIs), which are caused by contact with contaminated tools, bedclothes, and air droplets throughout facilities, is fueling market development. Furthermore, demand for home infusion therapy is rising to reduce the likelihood of infection and ensure the best possible care. Development of low-cost, user-friendly home infusion kits is another factor propelling the industry.

Rise in Prevalence of Cancer Propelling Infusion Therapy Market Demand

Cancer is the second leading cause of death globally. It occurs due to development of abnormal cells, which further divide uncontrollably. These abnormal cells further form a mass like structure, which is called tumor. According to the WHO, cancer accounted for nearly 10 million deaths globally in 2020, which is one in six deaths. The most common cancers are breast, prostrate, lung colon, and rectum.

Diabetes is another chronic disease, which leads to large number of deaths. According to the Centers for Disease Control and Prevention, around 37 million people die in the U.S. due to diabetes.

Cardiovascular diseases are the leading causes of death globally. Heart attacks and strokes are the most common acute events. These are primarily caused due to blockages in the blood vessels, which prevent the blood from flowing to the brain or heart. The reasons for heart failure could include unhealthy diet and addictions such as tobacco and smoking. According to the WHO, in 2019, CVDs accounted for an estimated 17.9 million deaths; of these 85% were due to heart attack and stroke, and more than 75% deaths occur in the low & middle income countries.

Thus, rise in the number of infusion therapies due to the increase in incidence of these chronic diseases is driving the infusion therapy market size.

Reduction of Human Errors Due to Advanced Infusion Pumps

Infusion pumps are used in various applications in the medical field. In some cases, there are chances of getting an incorrect infusion into a patient’s body, which could hamper a patient's health. However, advanced pumps are available that directly deliver fluids or medications more efficiently into the patient’s blood stream. This minimizes human errors. Advanced pumps, such as ‘Sigma Spectrum’ and other smart pumps, contain drug libraries with a digital regulation within the pump itself to minimize the errors.

The two basic classes of infusion pumps are large volume pumps and small volume pumps. Large volume pumps are used to deliver nutrients, while small pumps are utilized to deliver medications and hormones. In the case of chemotherapy infusion, the medicines (of around 100 agents) used to treat cancer are introduced through a pump that controls the rate and amount of infusion. Generally, chemotherapy medications are infused through a vein in the patient’s hand or arm. However, these are sometimes infused through a specific port or are injected under the skin. These medications further circulate in the body and fight against the disease.

Therefore, usage of advanced infusion pumps, such as IP-200 infusion system, that can minimize errors is likely to propel market expansion.

Increase in Demand for Portable Infusion Therapy Pumps

In terms of product, the accessories segment dominated the global industry in 2021. The trend is expected to continue during the forecast period. According to a featured article by Wolters Kluwer Health, Inc., over 90% of hospitalized patients in the U.S. received IV medications, with the majority of them delivered via portable infusion pump.

Rise in Prevalence of Cancer Fueling Market Progress

Based on indication, the cancer segment led the global infusion therapy market in 2021. Just as the prevalence of target illnesses such as cancer, viral infections, and tuberculosis (TB) has increased, so has the usage of IV infusion pump accessories.

Infusion products are used to administer analgesics, anesthetics, antipyretics, antibiotics, anticancer medications, and other medications. Usage of medications to treat or eliminate cancer cells is one of the most commonly adopted cancer treatments. Chemotherapy fights cancer cells in various ways, including interfering with the ability of cancer cells to grow or reproduce. Cancer is also commonly treated with more than one medicine at the same time. Chemotherapy could be used alone or in combination with other treatments such as radiation or surgery.

High Demand for Antibiotic/Antiviral Intravenous (IV) Infusion Therapy

In terms of therapy, the antibiotic/antiviral segment dominated the global market in 2021. The trend is expected to continue during the forecast period. Antibiotic intravenous (IV) infusion therapy is a common therapy in hospitals. It has gained popularity in the past few years, coinciding with the rise in bacterial resistance to several commonly used oral antibiotics. In these cases, antibiotic IV infusion therapy is the last line of defense against these types of bacteria, which are already one of the most serious threats to human health in the 21st century.

Surge in Coronavirus Cases Due to New Strains

Based on end-user, the hospitals segment dominated the global market in 2021. The trend is expected to continue during the forecast period. New coronavirus strains have been reported in several parts of the world, resulting in rise in cases. This has increased the number of hospital admissions.

Many patients are being placed on ventilators for critical care, particularly the elderly and those with severe lung infections. Intravenous solutions are constantly administered to such patients in order to maintain adequate nutrition.

Regional Analysis of Global Infusion Therapy Market

According to the infusion therapy industry report, North America held the largest share in 2021, led by the increase in medications used to treat chronic and uncommon diseases through infusion therapy. Rise in prevalence of chronic diseases such as cancer, cardiovascular diseases, and diabetes; increase in geriatric population; and rapid technological advancements in the healthcare sector contribute to the region's global dominance.

Investment in the healthcare market in North America has increased in the past few years. Improved quality of life due to economic development has propelled market expansion in the region.

The market in Asia Pacific is expected to grow at a rapid pace during the forecast period owing to rapid adoption of new technologies in the infusion therapy industry and rise in prevalence of chronic diseases.

Analysis of Key Players

Leading companies in the global market are Becton, Dickinson and Company, Baxter International Inc., B. Braun Melsungen AG, ICU Medical, Inc., Fresenius SE & Co. KGaA, Medtronic, Inc., Terumo Corporation, CareFusion Corporation, and Polymedicure. These companies are focusing on strategic acquisitions and partnerships to expand their product portfolio.

Key Developments in Global Infusion Therapy Market

  • In February 2022, B. Braun, one of the leading companies in the medical technology and a provider of infusion therapy & pain management solutions, received the FDA approval for Daytona Beach Pharmaceutical Manufacturing Site. The new Daytona Beach facility is part of the company's commitment to invest more than US$ 1 Bn in the U.S. to alleviate IV fluid shortages by increasing supply and manufacturing capacity. B. Braun now has strategic manufacturing locations on both coasts, thanks to its existing IV solutions plant in Irvine, California.

Prominent players have been profiled in the infusion therapy market report based on parameters such as product portfolio, recent developments, financial overview, company overview, strategies, and segments.

Global Infusion Therapy Market Snapshot

Attribute

Detail

Size in 2021

US$ 41.7 Bn

Forecast (Value) in 2031

More than US$ 78.9 Bn

Compound Annual Growth Rate (CAGR)

6.7%

Forecast Period

2022–2031

Historical Data Available for

2017–2021

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market share analysis by company (2021)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Segmentation

  • Product
    • Infusion Pumps
      • Ambulatory Infusion Pumps
      • Stationary Infusion Pumps
      • Syringe Infusion Pumps
      • Disposable Pumps
      • Large Volume Pumps
      • Elastomeric pumps
    • Infusion Set
    • Accessories
  • Indication
    • Cancer
    • Gastrointestinal Diseases/Disorders
    • Congestive Heart Failure
    • Rheumatoid Arthritis
    • Hemophilia
    • Immune Deficiencies
    • Others
  • Therapy
    • Antibiotic/Antiviral
    • Anti-coagulation
    • Anti-emetics
    • Blood Component Stimulating Factor
    • Chemotherapy
    • Nutrition
    • Hydration
    • Pain Management
  • End-user
    • Hospitals
    • Ambulatory Surgical Centers
    • Clinics
    • Homecare Settings

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • Japan
  • India
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • B. Braun Melsungen AG
  • Medtronic plc
  • Becton, Dickinson and Company
  • ICU medical (Smiths Medical)
  • Baxter International, Inc.
  • Polymedicure
  • BIO-MED
  • Terumo Medical Corporation
  • MEDIPRIM GmbH
  • Fresenius Kabi
  • Cardinal Health

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global infusion therapy market in 2021?

The global industry was valued at US$ 41.7 Bn in 2021

How big will it be in 2031?

It is projected to reach more than US$ 78.9 Bn by 2031

What was the CAGR from 2017 to 2021)?

The CAGR was 4.7% from 2017 to 2021

What will be the CAGR during the forecast period?

The CAGR is anticipated to be 6.7% from 2022 to 2031

What are the prominent trends that affect growth?

Rise in prevalence of chronic diseases such as cardiovascular & cancer and reduction of human errors due to advanced infusion pumps

What is the share of leading segment?

The accessories segment held more than 35.0% share in 2021

Which region is likely to account for major share?

North America is expected to account for significant share during the forecast period.

Who are the prominent players in the business?

Becton, Dickinson and Company, Baxter International, Inc., B. Braun Melsungen AG, ICU Medical, Inc., Fresenius SE & Co. KGaA, Medtronic, plc, Terumo Corporation, CareFusion Corporation, and Polymedicure

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Infusion Therapy Market

4. Market Overview

    4.1. Introduction

        4.1.1. Segment Definition

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Porter’s Five Force Analysis

5. Key Insights

    5.1. Key Industry Developments

    5.2. Disease Prevalence & Incidence Rate globally with key countries

    5.3. Technological Advancements

    5.4. Regulatory Scenario by Region/globally

    5.5. Covid-19 Pandemic impact on the industry

6. Global Infusion Therapy Market Analysis and Forecast, by Product

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Product, 2017–2031

        6.3.1. Infusion Pumps

            6.3.1.1. Ambulatory Infusion Pumps

            6.3.1.2. Stationary Infusion Pumps

            6.3.1.3. Syringe Infusion Pumps

            6.3.1.4. Disposable Pumps

            6.3.1.5. Large Volume Pumps

            6.3.1.6. Elastomeric Pumps

        6.3.2. Infusion Set

        6.3.3. Accessories

    6.4. Market Attractiveness Analysis, by Product

7. Global Infusion Therapy Market Analysis and Forecast, by Indication

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Indication, 2017–2031

        7.3.1. Cancer

        7.3.2. Gastrointestinal Diseases / Disorders

        7.3.3. Congestive Heart Failure

        7.3.4. Rheumatoid Arthritis

        7.3.5. Hemophilia

        7.3.6. Immune Deficiencies

        7.3.7. Others

    7.4. Market Attractiveness Analysis, by Indication

8. Global Infusion Therapy Market Analysis and Forecast, by Therapy Type

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by Therapy Type, 2017–2031

        8.3.1. Antibiotic/Antiviral

        8.3.2. Anti-coagulation

        8.3.3. Anti-emetics

        8.3.4. Blood Component Stimulating Factor

        8.3.5. Chemotherapy

        8.3.6. Nutrition

        8.3.7. Hydration

        8.3.8. Pain Management

    8.4. Market Attractiveness Analysis, by Therapy Type

9. Global Infusion Therapy Market Analysis and Forecast, by End-user

    9.1. Introduction & Definition

    9.2. Key Findings / Developments

    9.3. Market Value Forecast, by End-user, 2017–2031

        9.3.1. Hospitals

        9.3.2. Ambulatory Surgical Centers

        9.3.3. Clinics

        9.3.4. Homecare Settings

    9.4. Market Attractiveness Analysis, by End-user

10. Global Infusion Therapy Market Analysis and Forecast, by Region

    10.1. Key Findings

    10.2. Market Value Forecast, by Region

        10.2.1. North America

        10.2.2. Europe

        10.2.3. Asia Pacific

        10.2.4. Latin America

        10.2.5. Middle East & Africa

    10.3. Market Attractiveness Analysis, by Region

11. North America Infusion Therapy Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Product, 2017–2031

        11.2.1. Infusion Pumps

            11.2.1.1. Ambulatory Infusion Pumps

            11.2.1.2. Stationary Infusion Pumps

            11.2.1.3. Syringe Infusion Pumps

            11.2.1.4. Disposable Pumps

            11.2.1.5. Large Volume Pumps

            11.2.1.6. Elastomeric Pumps

        11.2.2. Infusion Set

        11.2.3. Accessories

    11.3. Market Value Forecast, by Indication, 2017–2031

        11.3.1. Cancer

        11.3.2. Gastrointestinal Diseases / Disorders

        11.3.3. Congestive Heart Failure

        11.3.4. Rheumatoid Arthritis

        11.3.5. Hemophilia

        11.3.6. Immune Deficiencies

        11.3.7. Others

    11.4. Market Value Forecast, by Therapy Type, 2017–2031

        11.4.1. Antibiotic/Antiviral

        11.4.2. Anti-coagulation

        11.4.3. Anti-emetics

        11.4.4. Blood Component Stimulating Factor

        11.4.5. Chemotherapy

        11.4.6. Nutrition

        11.4.7. Hydration

        11.4.8. Pain Management

    11.5. Market Value Forecast, by End-user, 2017–2031

        11.5.1. Hospitals

        11.5.2. Ambulatory Surgical Centers

        11.5.3. Clinics

        11.5.4. Homecare Settings

    11.6. Market Value Forecast, by Country, 2017–2031

        11.6.1. U.S.

        11.6.2. Canada

    11.7. Market Attractiveness Analysis

        11.7.1. By Product

        11.7.2. By Indication

        11.7.3. By Therapy Type

        11.7.4. By End-user

        11.7.5. By Country

12. Europe Infusion Therapy Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Product, 2017–2031

        12.2.1. Infusion Pumps

            12.2.1.1. Ambulatory Infusion Pumps

            12.2.1.2. Stationary Infusion Pumps

            12.2.1.3. Syringe Infusion Pumps

            12.2.1.4. Disposable Pumps

            12.2.1.5. Large Volume Pumps

            12.2.1.6. Elastomeric Pumps

        12.2.2. Infusion Set

        12.2.3. Accessories

    12.3. Market Value Forecast, by Indication, 2017–2031

        12.3.1. Cancer

        12.3.2. Gastrointestinal Diseases / Disorders

        12.3.3. Congestive Heart Failure

        12.3.4. Rheumatoid Arthritis

        12.3.5. Hemophilia

        12.3.6. Immune Deficiencies

        12.3.7. Others

    12.4. Market Value Forecast, by Therapy Type, 2017–2031

        12.4.1. Antibiotic/Antiviral

        12.4.2. Anti-coagulation

        12.4.3. Anti-emetics

        12.4.4. Blood Component Stimulating Factor

        12.4.5. Chemotherapy

        12.4.6. Nutrition

        12.4.7. Hydration

        12.4.8. Pain Management

    12.5. Market Value Forecast, by End-user, 2017–2031

        12.5.1. Hospitals

        12.5.2. Ambulatory Surgical Centers

        12.5.3. Clinics

        12.5.4. Homecare Settings

    12.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.6.1. Germany

        12.6.2. U.K.

        12.6.3. France

        12.6.4. Italy

        12.6.5. Spain

        12.6.6. Rest of Europe

    12.7. Market Attractiveness Analysis

        12.7.1. By Product

        12.7.2. By Indication

        12.7.3. By Therapy Type

        12.7.4. By End-user

        12.7.5. By Country/Sub-region

13. Asia Pacific Infusion Therapy Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Product, 2017–2031

        13.2.1. Infusion Pumps

            13.2.1.1. Ambulatory Infusion Pumps

            13.2.1.2. Stationary Infusion Pumps

            13.2.1.3. Syringe Infusion Pumps

            13.2.1.4. Disposable Pumps

            13.2.1.5. Large Volume Pumps

            13.2.1.6. Elastomeric Pumps

        13.2.2. Infusion Set

        13.2.3. Accessories

    13.3. Market Value Forecast, by Indication, 2017–2031

        13.3.1. Cancer

        13.3.2. Gastrointestinal Diseases / Disorders

        13.3.3. Congestive Heart Failure

        13.3.4. Rheumatoid Arthritis

        13.3.5. Hemophilia

        13.3.6. Immune Deficiencies

        13.3.7. Others

    13.4. Market Value Forecast, by Therapy Type, 2017–2031

        13.4.1. Antibiotic/Antiviral

        13.4.2. Anti-coagulation

        13.4.3. Anti-emetics

        13.4.4. Blood Component Stimulating Factor

        13.4.5. Chemotherapy

        13.4.6. Nutrition

        13.4.7. Hydration

        13.4.8. Pain Management

    13.5. Market Value Forecast, by End-user, 2017–2031

        13.5.1. Hospitals

        13.5.2. Ambulatory Surgical Centers

        13.5.3. Clinics

        13.5.4. Homecare Settings

    13.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.6.1. China

        13.6.2. Japan

        13.6.3. India

        13.6.4. Australia & New Zealand

        13.6.5. Rest of Asia Pacific

    13.7. Market Attractiveness Analysis

        13.7.1. By Product

        13.7.2. By Indication

        13.7.3. By Therapy Type

        13.7.4. By End-user

        13.7.5. By Country/Sub-region

14. Latin America Infusion Therapy Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Product, 2017–2031

        14.2.1. Infusion Pumps

            14.2.1.1. Ambulatory Infusion Pumps

            14.2.1.2. Stationary Infusion Pumps

            14.2.1.3. Syringe Infusion Pumps

            14.2.1.4. Disposable Pumps

            14.2.1.5. Large Volume Pumps

            14.2.1.6. Elastomeric Pumps

        14.2.2. Infusion Set

        14.2.3. Accessories

    14.3. Market Value Forecast, by Indication, 2017–2031

        14.3.1. Cancer

        14.3.2. Gastrointestinal Diseases / Disorders

        14.3.3. Congestive Heart Failure

        14.3.4. Rheumatoid Arthritis

        14.3.5. Hemophilia

        14.3.6. Immune Deficiencies

        14.3.7. Others

    14.4. Market Value Forecast, by Therapy Type, 2017–2031

        14.4.1. Antibiotic/Antiviral

        14.4.2. Anti-coagulation

        14.4.3. Anti-emetics

        14.4.4. Blood Component Stimulating Factor

        14.4.5. Chemotherapy

        14.4.6. Nutrition

        14.4.7. Hydration

        14.4.8. Pain Management

    14.5. Market Value Forecast, by End-user, 2017–2031

        14.5.1. Hospitals

        14.5.2. Ambulatory Surgical Centers

        14.5.3. Clinics

        14.5.4. Homecare Settings

    14.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        14.6.1. Brazil

        14.6.2. Mexico

        14.6.3. Rest of Latin America

    14.7. Market Attractiveness Analysis

        14.7.1. By Product

        14.7.2. By Indication

        14.7.3. By Therapy Type

        14.7.4. By End-user

        14.7.5. By Country/Sub-region

15. Middle East & Africa Infusion Therapy Market Analysis and Forecast

    15.1. Introduction

        15.1.1. Key Findings

    15.2. Market Value Forecast, by Product, 2017–2031

        15.2.1. Infusion Pumps

            15.2.1.1. Ambulatory Infusion Pumps

            15.2.1.2. Stationary Infusion Pumps

            15.2.1.3. Syringe Infusion Pumps

            15.2.1.4. Disposable Pumps

            15.2.1.5. Large Volume Pumps

            15.2.1.6. Elastomeric Pumps

        15.2.2. Infusion Set

        15.2.3. Accessories

    15.3. Market Value Forecast, by Indication, 2017–2031

        15.3.1. Cancer

        15.3.2. Gastrointestinal Diseases / Disorders

        15.3.3. Congestive Heart Failure

        15.3.4. Rheumatoid Arthritis

        15.3.5. Hemophilia

        15.3.6. Immune Deficiencies

        15.3.7. Others

    15.4. Market Value Forecast, by Therapy Type, 2017–2031

        15.4.1. Antibiotic/Antiviral

        15.4.2. Anti-coagulation

        15.4.3. Anti-emetics

        15.4.4. Blood Component Stimulating Factor

        15.4.5. Chemotherapy

        15.4.6. Nutrition

        15.4.7. Hydration

        15.4.8. Pain Management

    15.5. Market Value Forecast, by End-user, 2017–2031

        15.5.1. Hospitals

        15.5.2. Ambulatory Surgical Centers

        15.5.3. Clinics

        15.5.4. Homecare Settings

    15.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        15.6.1. GCC Countries

        15.6.2. South Africa

        15.6.3. Rest of Middle East & Africa

    15.7. Market Attractiveness Analysis

        15.7.1. By Product

        15.7.2. By Indication

        15.7.3. By Therapy Type

        15.7.4. By End-user

        15.7.5. By Country/Sub-region

16. Competition Landscape

    16.1. Market Player - Competition Matrix (by tier and size of companies)

    16.2. Market Share Analysis, by Company, 2021

    16.3. Company Profiles

        16.3.1. B. Braun Melsungen AG

            16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.1.2. Product Portfolio

            16.3.1.3. Financial Overview

            16.3.1.4. SWOT Analysis

            16.3.1.5. Strategic Overview

        16.3.2. Medtronic plc

            16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.2.2. Product Portfolio

            16.3.2.3. Financial Overview

            16.3.2.4. SWOT Analysis

            16.3.2.5. Strategic Overview

        16.3.3. Becton, Dickinson and Company

            16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.3.2. Product Portfolio

            16.3.3.3. Financial Overview

            16.3.3.4. SWOT Analysis

            16.3.3.5. Strategic Overview

        16.3.4. ICU medical (Smiths Medical)

            16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.4.2. Product Portfolio

            16.3.4.3. Financial Overview

            16.3.4.4. SWOT Analysis

            16.3.4.5. Strategic Overview

        16.3.5. Baxter International, Inc.

            16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.5.2. Product Portfolio

            16.3.5.3. Financial Overview

            16.3.5.4. SWOT Analysis

            16.3.5.5. Strategic Overview

        16.3.6. Polymedicure

            16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.6.2. Product Portfolio

            16.3.6.3. Financial Overview

            16.3.6.4. SWOT Analysis

            16.3.6.5. Strategic Overview

        16.3.7. BIO-MED

            16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.7.2. Product Portfolio

            16.3.7.3. Financial Overview

            16.3.7.4. SWOT Analysis

            16.3.7.5. Strategic Overview

        16.3.8. Terumo Medical Corporation

            16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.8.2. Product Portfolio

            16.3.8.3. Financial Overview

            16.3.8.4. SWOT Analysis

            16.3.8.5. Strategic Overview

        16.3.9. MEDIPRIM GmbH

            16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.9.2. Product Portfolio

            16.3.9.3. Financial Overview

            16.3.9.4. SWOT Analysis

            16.3.9.5. Strategic Overview

        16.3.10. Fresenius Kabi

            16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.10.2. Product Portfolio

            16.3.10.3. Financial Overview

            16.3.10.4. SWOT Analysis

            16.3.10.5. Strategic Overview

        16.3.11. Cardinal Health

            16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.11.2. Product Portfolio

            16.3.11.3. Financial Overview

            16.3.11.4. SWOT Analysis

            16.3.11.5. Strategic Overview

List of Tables

Table 01: Global Infusion Therapy Market Value (US$ Bn) Forecast, by Product, 2017–2031

Table 02: Global Infusion Therapy Market Value (US$ Bn) Forecast, by Infusion Pumps, 2017–2031

Table 03: Global Infusion Therapy Market Value (US$ Bn) Forecast, by Indication, 2017–2031

Table 04: Global Infusion Therapy Market Value (US$ Bn) Forecast, by Therapy, 2017–2031

Table 05: Global Infusion Therapy Market Value (US$ Bn) Forecast, by End-user, 2017–2031

Table 06: Global Infusion Therapy Market Value (US$ Bn) Forecast, by Region, 2017–2031 

Table 07: North America Infusion Therapy Market Value (US$ Bn) Forecast, by Country, 2017–2031

Table 08: North America Infusion Therapy Market Value (US$ Bn) Forecast, by Product, 2017–2031

Table 09: North America Infusion Therapy Market Value (US$ Bn) Forecast, by Infusion Pumps, 2017–2031

Table 10: North America Infusion Therapy Market Value (US$ Bn) Forecast, by Indication, 2017–2031

Table 11: North America Infusion Therapy Market Value (US$ Bn) Forecast, by Therapy, 2017–2031

Table 12: North America Infusion Therapy Market Value (US$ Bn) Forecast, by End-user, 2017–2031

Table 13: Europe Infusion Therapy Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Europe Infusion Therapy Market Value (US$ Bn) Forecast, by Product, 2017–2031

Table 15: Europe Infusion Therapy Market Value (US$ Bn) Forecast, by Infusion Pumps, 2017–2031

Table 16: Europe Infusion Therapy Market Value (US$ Bn) Forecast, by Indication, 2017–2031

Table 17: Europe Infusion Therapy Market Value (US$ Bn) Forecast, by Therapy, 2017–2031

Table 18: Europe Infusion Therapy Market Value (US$ Bn) Forecast, by End-user, 2017–2031

Table 19: Asia Pacific Infusion Therapy Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031

Table 20: Asia Pacific Infusion Therapy Market Value (US$ Bn) Forecast, by Product, 2017–2031

Table 21: Asia Pacific Infusion Therapy Market Value (US$ Bn) Forecast, by Infusion Pumps, 2017–2031

Table 22: Asia Pacific Infusion Therapy Market Value (US$ Bn) Forecast, by Indication, 2017–2031

Table 23: Asia Pacific Infusion Therapy Market Value (US$ Bn) Forecast, by Therapy, 2017–2031

Table 24: Asia Pacific Infusion Therapy Market Value (US$ Bn) Forecast, by End-user, 2017–2031

Table 25: Latin America Infusion Therapy Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031

Table 26: Latin America Infusion Therapy Market Value (US$ Bn) Forecast, by Product, 2017–2031

Table 27: Latin America Infusion Therapy Market Value (US$ Bn) Forecast, by Infusion Pumps, 2017–2031

Table 28: Latin America Infusion Therapy Market Value (US$ Bn) Forecast, by Indication, 2017–2031

Table 29: Latin America Infusion Therapy Market Value (US$ Bn) Forecast, by Therapy, 2017–2031

Table 30: Latin America Infusion Therapy Market Value (US$ Bn) Forecast, by End-user, 2017–2031

Table 31: Middle East & Africa Infusion Therapy Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031

Table 32: Middle East & Africa Infusion Therapy Market Value (US$ Bn) Forecast, by Product, 2017–2031

Table 33: Middle East & Africa Infusion Therapy Market Value (US$ Bn) Forecast, by Infusion Pumps, 2017–2031

Table 34: Middle East & Africa Infusion Therapy Market Value (US$ Bn) Forecast, by Indication, 2017–2031

Table 35: Middle East & Africa Infusion Therapy Market Value (US$ Bn) Forecast, by Therapy, 2017–2031

Table 36: Middle East & Africa Infusion Therapy Market Value (US$ Bn) Forecast, by End-user, 2017–2031

List of Figures

Figure 01: Global Infusion Therapy Market Value Share, by Product, 2021 and 2031

Figure 02: Global Infusion Therapy Market Attractiveness Analysis, Product, 2022–2031

Figure 03: Global Infusion Therapy Market (US$ Bn), by Infusion Pumps, 2017–2031

Figure 04: Global Infusion Therapy Market (US$ Bn), by Infusion Set, 2017–2031

Figure 05: Global Infusion Therapy Market (US$ Bn), by Accessories, 2017–2031

Figure 06: Global Infusion Therapy Market, by Indication, 2021 and 2031

Figure 07: Global Infusion Therapy Market Attractiveness Analysis, Indication, 2022–2031

Figure 08: Global Infusion Therapy Market (US$ Bn), by Cancer, 2017–2031

Figure 09: Global Infusion Therapy Market (US$ Bn), by Gastrointestinal Diseases/Disorders, 2017–2031

Figure 10: Global Infusion Therapy Market (US$ Bn), by Congestive Heart Failure, 2017–2031

Figure 11: Global Infusion Therapy Market (US$ Bn), by Rheumatoid Arthritis, 2017–2031

Figure 12: Global Infusion Therapy Market (US$ Bn), by Hemophilia, 2017–2031

Figure 13: Global Infusion Therapy Market (US$ Bn), by Immune Deficiencies, 2017–2031

Figure 14: Global Infusion Therapy Market (US$ Bn), by Others, 2017–2031

Figure 15: Global Infusion Therapy Market, by Therapy, 2021 and 2031

Figure 16: Global Infusion Therapy Market Attractiveness Analysis, Therapy, 2022–2031

Figure 17: Global Infusion Therapy Market (US$ Bn), by Antibiotic/Antiviral, 2017–2031

Figure 18: Global Infusion Therapy Market (US$ Bn), by Anti-coagulation, 2017–2031

Figure 19: Global Infusion Therapy Market (US$ Bn), by Anti-emetics, 2017–2031

Figure 20: Global Infusion Therapy Market (US$ Bn), by Blood Component Stimulating Factor, 2017–2031

Figure 21: Global Infusion Therapy Market (US$ Bn), by Chemotherapy, 2017–2031

Figure 22: Global Infusion Therapy Market (US$ Bn), by Nutrition, 2017–2031

Figure 23: Global Infusion Therapy Market (US$ Bn), by Hydration, 2017–2031

Figure 24: Global Infusion Therapy Market (US$ Bn), by Pain Management, 2017–2031

Figure 25: Global Infusion Therapy Market, by End-user, 2021 and 2031

Figure 26: Global Infusion Therapy Market Attractiveness Analysis, End-user, 2022–2031

Figure 27: Global Infusion Therapy Market (US$ Bn), by Hospitals, 2017–2031

Figure 28: Global Infusion Therapy Market (US$ Bn), by Ambulatory Surgical Centers, 2017–2031

Figure 29: Global Infusion Therapy Market (US$ Bn), by Clinics, 2017–2031

Figure 30: Global Infusion Therapy Market (US$ Bn), by Homecare Settings, 2017–2031

Figure 31: Global Infusion Therapy Market Value Share Analysis, by Region, 2021 and 2031

Figure 32: Global Infusion Therapy Market Attractiveness Analysis, by Region, 2022–2031

Figure 33: North America Infusion Therapy Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 34: North America Infusion Therapy Market Value Share Analysis, by Country, 2021 and 2031

Figure 35: North America Infusion Therapy Market Attractiveness Analysis, by Country, 2022–2031

Figure 36: North America Infusion Therapy Market Value Share Analysis, by Product, 2021 and 2031

Figure 37: North America Infusion Therapy Market Attractiveness Analysis, by Product, 2022–2031

Figure 38: North America Infusion Therapy Market Value Share Analysis, by Indication, 2021 and 2031

Figure 39: North America Infusion Therapy Market Attractiveness Analysis, by Indication, 2022–2031

Figure 40: North America Infusion Therapy Market Value Share Analysis, by Therapy, 2021 and 2031

Figure 41: North America Infusion Therapy Market Attractiveness Analysis, by Therapy, 2022–2031

Figure 42: North America Infusion Therapy Market Value Share Analysis, by End-user, 2021 and 2031

Figure 43: North America Infusion Therapy Market Attractiveness Analysis, by End-user, 2022–2031

Figure 44: Europe Infusion Therapy Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 45: Europe Infusion Therapy Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 46: Europe Infusion Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 47: Europe Infusion Therapy Market Value Share Analysis, by Product, 2021 and 2031

Figure 48: Europe Infusion Therapy Market Attractiveness Analysis, by Product, 2022–2031

Figure 49: Europe Infusion Therapy Market Value Share Analysis, by Indication, 2021 and 2031

Figure 50: Europe Infusion Therapy Market Attractiveness Analysis, by Indication, 2022–2031

Figure 51: Europe Infusion Therapy Market Value Share Analysis, by Therapy, 2021 and 2031

Figure 52: Europe Infusion Therapy Market Attractiveness Analysis, by Therapy, 2022–2031

Figure 53: Europe Infusion Therapy Market Value Share Analysis, by End-user, 2021 and 2031

Figure 54: Europe Infusion Therapy Market Attractiveness Analysis, by End-user, 2022–2031

Figure 55: Asia Pacific Infusion Therapy Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 56: Asia Pacific Infusion Therapy Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 57: Asia Pacific Infusion Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 58: Asia Pacific Infusion Therapy Market Value Share Analysis, by Product, 2021 and 2031

Figure 59: Asia Pacific Infusion Therapy Market Attractiveness Analysis, by Product, 2022–2031

Figure 60: Asia Pacific Infusion Therapy Market Value Share Analysis, by Indication, 2021 and 2031

Figure 61: Asia Pacific Infusion Therapy Market Attractiveness Analysis, by Indication, 2022–2031

Figure 62: Asia Pacific Infusion Therapy Market Value Share Analysis, by Therapy, 2021 and 2031

Figure 63: Asia Pacific Infusion Therapy Market Attractiveness Analysis, by Therapy, 2022–2031

Figure 64: Asia Pacific Infusion Therapy Market Value Share Analysis, by End-user, 2021 and 2031

Figure 65: Asia Pacific Infusion Therapy Market Attractiveness Analysis, by End-user, 2022–2031

Figure 66: Latin America Infusion Therapy Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 67: Latin America Infusion Therapy Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 68: Latin America Infusion Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 69: Latin America Infusion Therapy Market Value Share Analysis, by Product, 2021 and 2031

Figure 70: Latin America Infusion Therapy Market Attractiveness Analysis, by Product, 2022–2031

Figure 71: Latin America Infusion Therapy Market Value Share Analysis, by Indication, 2021 and 2031

Figure 72: Latin America Infusion Therapy Market Attractiveness Analysis, by Indication, 2022–2031

Figure 73: Latin America Infusion Therapy Market Value Share Analysis, by Therapy, 2021 and 2031

Figure 74: Latin America Infusion Therapy Market Attractiveness Analysis, by Therapy, 2022–2031

Figure 75: Latin America Infusion Therapy Market Value Share Analysis, by End-user, 2021 and 2031

Figure 76: Latin America Infusion Therapy Market Attractiveness Analysis, by End-user, 2022–2031

Figure 77: Middle East & Africa Infusion Therapy Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 78: Middle East & Africa Infusion Therapy Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 79: Middle East & Africa Infusion Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 80: Middle East & Africa Infusion Therapy Market Value Share Analysis, by Product, 2021 and 2031

Figure 81: Middle East & Africa Infusion Therapy Market Attractiveness Analysis, by Product, 2022–2031

Figure 82: Middle East & Africa Infusion Therapy Market Value Share Analysis, by Indication, 2021 and 2031

Figure 83: Middle East & Africa Infusion Therapy Market Attractiveness Analysis, by Indication, 2022–2031

Figure 84: Middle East & Africa Infusion Therapy Market Value Share Analysis, by Therapy, 2021 and 2031

Figure 85: Middle East & Africa Infusion Therapy Market Attractiveness Analysis, by Therapy, 2022–2031

Figure 86: Middle East & Africa Infusion Therapy Market Value Share Analysis, by End-user, 2021 and 2031

Figure 87: Middle East & Africa Infusion Therapy Market Attractiveness Analysis, by End-user, 2022–2031

Copyright © Transparency Market Research, Inc. All Rights reserved